Cargando…

Optimal group testing with heterogeneous risks

We consider optimal group testing of individuals with heterogeneous risks for an infectious disease. Our algorithm significantly reduces the number of tests needed compared to Dorfman (Ann Math Stat 14(4):436–440, 1943). When both low-risk and high-risk samples have sufficiently low infection probab...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobkova, Nina, Chen, Ying, Eraslan, Hülya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243685/
https://www.ncbi.nlm.nih.gov/pubmed/37360771
http://dx.doi.org/10.1007/s00199-023-01502-3
_version_ 1785054477898743808
author Bobkova, Nina
Chen, Ying
Eraslan, Hülya
author_facet Bobkova, Nina
Chen, Ying
Eraslan, Hülya
author_sort Bobkova, Nina
collection PubMed
description We consider optimal group testing of individuals with heterogeneous risks for an infectious disease. Our algorithm significantly reduces the number of tests needed compared to Dorfman (Ann Math Stat 14(4):436–440, 1943). When both low-risk and high-risk samples have sufficiently low infection probabilities, it is optimal to form heterogeneous groups with exactly one high-risk sample per group. Otherwise, it is not optimal to form heterogeneous groups, but homogeneous group testing may still be optimal. For a range of parameters including the U.S. Covid-19 positivity rate for many weeks during the pandemic, the optimal size of a group test is four. We discuss the implications of our results for team design and task assignment.
format Online
Article
Text
id pubmed-10243685
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-102436852023-06-07 Optimal group testing with heterogeneous risks Bobkova, Nina Chen, Ying Eraslan, Hülya Econ Theory Research Article We consider optimal group testing of individuals with heterogeneous risks for an infectious disease. Our algorithm significantly reduces the number of tests needed compared to Dorfman (Ann Math Stat 14(4):436–440, 1943). When both low-risk and high-risk samples have sufficiently low infection probabilities, it is optimal to form heterogeneous groups with exactly one high-risk sample per group. Otherwise, it is not optimal to form heterogeneous groups, but homogeneous group testing may still be optimal. For a range of parameters including the U.S. Covid-19 positivity rate for many weeks during the pandemic, the optimal size of a group test is four. We discuss the implications of our results for team design and task assignment. Springer Berlin Heidelberg 2023-06-06 /pmc/articles/PMC10243685/ /pubmed/37360771 http://dx.doi.org/10.1007/s00199-023-01502-3 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Article
Bobkova, Nina
Chen, Ying
Eraslan, Hülya
Optimal group testing with heterogeneous risks
title Optimal group testing with heterogeneous risks
title_full Optimal group testing with heterogeneous risks
title_fullStr Optimal group testing with heterogeneous risks
title_full_unstemmed Optimal group testing with heterogeneous risks
title_short Optimal group testing with heterogeneous risks
title_sort optimal group testing with heterogeneous risks
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243685/
https://www.ncbi.nlm.nih.gov/pubmed/37360771
http://dx.doi.org/10.1007/s00199-023-01502-3
work_keys_str_mv AT bobkovanina optimalgrouptestingwithheterogeneousrisks
AT chenying optimalgrouptestingwithheterogeneousrisks
AT eraslanhulya optimalgrouptestingwithheterogeneousrisks